Scarica l'app Stockscreener
39.95
0.53%
0.21
Dopo l'orario di chiusura:
39.17
-0.78
-1.95%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché IMVT Giù?
Forum
Previsione
Immunovant Inc Borsa (IMVT) Ultime notizie
Immunovant: Risk-Reward Set-Up Compelling, Initiating With A Speculative Buy - Seeking Alpha
Immunovant Inc (IMVT) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Immunovant Inc (IMVT) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Immunovant to Report Financial Results for the First Quarter Ended June 30, 2026, and Provide Business Update on Thursday, August 6, 2026 - marketscreener.com
Immunovant Inc (IMVT) Cash Flow - TradingKey
Immunovant Insider Sold Shares Worth $263,015, According to a Recent SEC Filing - marketscreener.com
Immunovant Inc (IMVT) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Immunovant Inc (IMVT) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Immunovant Inc (IMVT) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
IMVT|Immunovant Inc|Price:39.410|Chg%:+0.040 - TradingKey
Immunovant CFO Tiago Girao sells $263,014 in company stock By Investing.com - Investing.com India
Immunovant director Atul Pande sells $59,699 in shares By Investing.com - Investing.com Canada
Immunovant director Atul Pande sells $59,699 in shares - Investing.com
Immunovant CFO Tiago Girao sells $263,014 in company stock - Investing.com
Immunovant CTO Jay Stout sells $110,537 in shares - Investing.com
Form 4 Immunovant Inc For: 24 July By Investing.com - Investing.com Nigeria
Immunovant CTO Jay Stout Executes Share Sale to Meet Tax Obligations Post-RSU Vesting - Kalkine Media
Immunovant (IMVT) CTO sells 2,857 shares in mandated tax sell-to-cover - Stock Titan
Immunovant director Atul Pande disposes of 1,500 common shares for $59,700 - Bitget
Immunovant updates financial calendar with first-quarter results release and business update call - Bitget
Immunovant, Inc. ($IMVT) CEO 2026 Pay Revealed - Quiver Quantitative
Immunovant, Inc. SEC Filing (Jul 22, 2026) - Stock Titan
Immunovant (NASDAQ: IMVT) plans 2026 votes on directors, auditor and pay - Stock Titan
Law firm investigates Immunovant officers for p... - Pluang
Understanding Momentum Shifts in (IMVT) - Stock Traders Daily
Immunovant Inc. (IMVT) Q2 2026 Earnings: Wider-than-Expected Loss Highlights Ongoing R&D InvestmentOne-Time Loss Impact - dars.gov.et
Immunovant chief legal officer Van Tuyl sells $47,702 in stock By Investing.com - Investing.com India
Immunovant CTO Jay Stout sells $137,924 in IMVT stock - Investing.com
Immunovant CTO Jay Stout sells $137,924 in IMVT stock By Investing.com - Investing.com South Africa
Form 4 Immunovant Inc For: 10 July By Investing.com - Investing.com Nigeria
Immunovant chief legal officer Van Tuyl sells $47,702 in stock - Investing.com
Immunovant COO Melanie Gloria sells $80,531 in shares By Investing.com - Investing.com South Africa
Immunovant COO Melanie Gloria sells $80,531 in shares - Investing.com
Immunovant (IMVT) COO offloads 2,036 shares to cover RSU tax withholding - Stock Titan
Immunovant (IMVT) legal chief sells 1,206 shares in tax “sell to cover” - Stock Titan
Immunovant (IMVT) CTO offloads 3,487 shares in mandated RSU tax-withholding sales - Stock Titan
LifeSci Capital Maintains Immunovant(IMVT.US) With Buy Rating, Raises Target Price to $53 - Moomoo
Emerging Therapies Transforming the Myasthenia Gravis Market by DelveInsight | Sanofi, Cartesian Therapeutics, Takeda, UCB Biopharma, Roche, Janssen R&D, Immunovant Sciences GmbH, Argenx-Halozyme - Barchart.com
Immunovant Inc explores long term growth paths as autoimmune pipeline advances - Ad-hoc-news.de
Immunovant stock hits 52-week high at 39.28 USD By Investing.com - Investing.com South Africa
Immunovant stock hits 52-week high at 39.28 USD - Investing.com
Immunovant Inc outlines its autoimmune drug pipeline as investors watch clinical milestones - Ad-hoc-news.de
Form 4 Immunovant Inc For: 6 July By Investing.com - Investing.com Nigeria
Immunovant CEO Eric Venker sells $118,980 of IMVT stock - Investing.com UK
Immunovant CEO Eric Venker sells $118,980 of IMVT stock By Investing.com - Investing.com Nigeria
1.84%
0.86%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):